| Name | Title | Contact Details |
|---|
RxSense is a high growth and mission-driven healthcare technology company that provides sophisticated cloud-based enterprise solutions for flexible, efficient, and transparent pharmacy benefits administration, claims processing and advanced analytics serving pharmacy benefit managers, health plans, health systems, as well as new and non-traditional industry entrants. RxSense also utilizes its advanced platform and direct contracts with the nation`s largest pharmacies (including CVS, Walmart and Walgreens) to deliver consistently low prices direct to consumers on prescription drugs through both its SingleCare (www.singlecare.com) and FamilyWize (www.familywize.org) prescription savings services. RxSense`s mission is to deliver industry leading technology solutions that improve healthcare transparency and access to more affordable medications for millions across America.
MarketSphere Consulting is a Omaha, NE-based company in the Computers and Electronics sector.
Edventure Software Inc is a San Jose, CA-based company in the Computers and Electronics sector.
Coffing Data Warehousing is a Middletown, OH-based company in the Computers and Electronics sector.
IdentifySensors is a leading developer of digital diagnostic technologies on graphene-based biosensors. The company is principally focused on developing real-time pathogen detection capabilities for direct diagnosis and remote monitoring. The company`s technology has expanded into multiple industries and applications, such as pathogen diagnostics and testing for food contamination. Check4® by IdentifySensors Biologics® is a next-generation digital diagnostic platform intended to detect multiple pathogens within 5 minutes at the molecular gene level. The platform is intended to eliminates the need for enzymatic amplification and reagents. Graphene sensor technology has moved diagnostics beyond chemical testing into a rapid digital platform intended to be as accurate as a PCR test but significantly more sensitive and cost effective. Printed graphene sensors isolate targeted viruses and bacteria from saliva and other bodily fluids within a handheld, Bluetooth device. The platform is intended to detect the genetic material of dozens of pathogens for over-the-counter and point-of-care use. With a target price at a fraction of current molecular tests, Check4® is intended to disrupt the PCR market for many infections. The Check4® testing platform comes is two main parts: 1) A reader, which connects to a user`s cell phone or to a clinical database; and 2) Single-use test cartridges, which can contain multiple graphene sensors to detect multiple infections. The reader, which can be reused thousands of times, serves as the base of the platform, accepting any number of test cartridges. Disposable test cartridges, which require the reader to work, will be sold separately.